Apiam Animal Health Limited (ASX:AHX) Managing Director Dr. Chris Richards outlines the Apiam brand and growing business, with veterinary practices joining the Apiam brand.
Proteomics International Laboratories Ltd (ASX:PIQ) in collaboration with Janssen Research & Development have shown that treatment with Canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce results showing a significant reduction in the PromarkerD risk scores of patients with type 2 diabetes after taking the diabetes medicine canagliflozin.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to provide the following update on its business activities for the three months to 31 March 2023 and subsequent to the period end.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce it has appointed additional members to its Clinical Advisory Board adding world leading healthcare professionals from the United States.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that the National Association of Testing Authorities (NATA) of Australia has approved the continuation of the Company's ISO 17025 accreditation.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its potential new world-first blood test for diagnosing endometriosis.
